These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Development of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the detection and identification of Campylobacter jejuni, Campylobacter coli and Campylobacter fetus. Asakura M; Samosornsuk W; Hinenoya A; Misawa N; Nishimura K; Matsuhisa A; Yamasaki S FEMS Immunol Med Microbiol; 2008 Mar; 52(2):260-6. PubMed ID: 18248435 [TBL] [Abstract][Full Text] [Related]
29. [Difference in oxygen requirements between the metronidazole-sensitive parent strain and its resistant variant of Campylobacter jejuni]. Narikawa S; Nakashio S; Koinuma I; Harasawa I; Nakamura M; Yoshizaki E; Kamiki T Nihon Saikingaku Zasshi; 1982 May; 37(3):619-21. PubMed ID: 7131777 [No Abstract] [Full Text] [Related]
30. Toxin receptors and their pathogenetic significance. Gyr K Acta Histochem Suppl; 1984; 29():95-102. PubMed ID: 6425929 [TBL] [Abstract][Full Text] [Related]
31. A Cytolethal Distending Toxin Gene-Based Multiplex PCR Assay for Campylobacter jejuni, C. fetus, C. coli, C. upsaliensis, C. hyointestinalis, and C. lari. Kamei K; Kawabata H; Asakura M; Samosornsuk W; Hinenoya A; Nakagawa S; Yamasaki S Jpn J Infect Dis; 2016 May; 69(3):256-8. PubMed ID: 26255737 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the identification of Campylobacter strains isolated from diarrheal patients in Japan. Kabir SM; Kikuchi K; Asakura M; Shiramaru S; Tsuruoka N; Goto A; Hinenoya A; Yamasaki S Jpn J Infect Dis; 2011; 64(1):19-27. PubMed ID: 21266751 [TBL] [Abstract][Full Text] [Related]
33. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model. Saha S; Sanyal SC Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342 [TBL] [Abstract][Full Text] [Related]
35. Immunological properties and ganglioside recognitions by Campylobacter jejuni-enterotoxin and cholera toxin. Suzuki S; Kawaguchi M; Mizuno K; Takama K; Yuki N FEMS Immunol Med Microbiol; 1994 Mar; 8(3):207-11. PubMed ID: 8004056 [TBL] [Abstract][Full Text] [Related]
36. Enterotoxigenicity and frequency of Campylobacter jejuni, C. coli and C. laridis in human and animal stool isolates from different countries. Lindblom GB; Johny M; Khalil K; Mazhar K; Ruiz-Palacios GM; Kaijser B FEMS Microbiol Lett; 1990 Jan; 54(1-3):163-7. PubMed ID: 2323537 [TBL] [Abstract][Full Text] [Related]
38. Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin. Albert MJ; Haridas S; Steer D; Dhaunsi GS; Smith AI; Adler B Infect Immun; 2007 Jun; 75(6):3070-3. PubMed ID: 17438040 [TBL] [Abstract][Full Text] [Related]
39. Survey of Campylobacter jejuni and enterotoxigenic Escherichia coli in Kenya. Shimotori S; Ehara M; Watanabe S; Ichinose Y; Waiyake PG; Kibue AM; Sang FC; Ngugi J Fukuoka Igaku Zasshi; 1986 Nov; 77(11):584-90. PubMed ID: 3546042 [No Abstract] [Full Text] [Related]